Trends in Molecular Medicine

Just say NO to muscle degeneration?
pp. 51-53(3)
Author: Froehner S.C.

Is MIF a central messenger in colitis?
pp. 55-55(1)
Author: Michie C.A.

New pathway for nuclear entry of HIV-1
pp. 55-55(1)
Author: Klein D.

In Brief
pp. 56-57(2)
Authors: Weitzman J.; O'Neill P.

Sickle cell gene therapy
pp. 56-56(1)
Author: Caplen N.J.

Cannabinoids and brain injury: therapeutic implications
pp. 58-61(4)
Authors: Mechoulam R.; Panikashvili D.; Shohami E.

Recent advances in insulin gene therapy for type 1 diabetes
pp. 62-68(7)
Authors: Yoon J.-W.; Jun H.-S.

Antibody-directed therapies for hematological malignancies
pp. 69-76(8)
Authors: Linenberger M.L.; Maloney D.G.; Bernstein I.D.

Molecular basis of resistance to azole antifungals
pp. 76-81(6)
Authors: Lupetti A.; Danesi R.; Campa M.; Tacca M.D.; Kelly S.

Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention
pp. 82-88(7)
Authors: Park W.-C.; Jordan V.C.

Of mice, men and motor neurons
pp. 88-92(5)
Authors: Newbery H.J.; Abbott C.M.

International research ethics: progress, but not perfection
pp. 93-95(3)
Authors: Jesus J.E.; Higgs E.S.

Cancer Research UK looks to NCI forsuccess
pp. 96-97(2)
Author: Rutherford A.

The cardiovascular system finally joins the lungs
pp. 97-98(2)
Author: Getz G.

Understanding neurodegeneration: beyond basics
pp. 98-98(1)
Author: Gurwitz D.